Multi-Stage Microfluidic Device for CTC Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for separating circulating tumor cells (CTCs) from blood face challenges such as low throughput, low recovery rates, and contamination due to the heterogeneity of CTCs and the need for labeling, which complicates molecular analysis and cell integrity.
Innovation Solution
A multi-stage microfluidic device combining filters, sheathing separation, and flow focusing, which uses a ferrofluid and magnetic focusing to enrich CTCs without labeling, achieving high throughput and maintaining cell integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If label-based CTC separation technologies are used to selectively enrich CTCs from blood, then the purity of isolated cancer cells is improved, but the cell integrity is worsened because cells are either dead or immobilized to a surface
Solution Approach 1:
The patent replaces mechanical/chemical labeling systems with a magnetic field-based separation system. Magnetic beads functionalized with antibodies are used to label CTCs, and a magnetic field gradient is applied to separate labeled cells from unlabeled cells in a continuous flow stream, eliminating the need for surface immobilization or chemical fixation that compromises cell integrity
Solution Approach 2:
The patent introduces magnetic beads as an intermediary carrier that binds to CTCs via antibody-antigen recognition. These magnetically labeled cells then serve as the target for magnetic field-based separation, allowing indirect manipulation of CTCs without direct contact with surfaces that would compromise their viability
2Reliability
If label-free methods are used to separate CTCs based on size, then the cell integrity is improved, but the purity is worsened due to overlapping sizes with white blood cells
Solution Approach 1:
The patent performs preliminary labeling of CTCs with magnetic beads before separation. This pre-labeling step enables subsequent magnetic field-based separation to distinguish CTCs from white blood cells based on magnetic susceptibility rather than size, resolving the overlap problem while maintaining cell integrity throughout the process
Solution Approach 2:
The patent changes the separation parameter from physical size to magnetic susceptibility. By introducing magnetic labeling, the separation mechanism transitions from size-based filtration to magnetic field-based deflection, allowing discrimination between CTCs and white blood cells that have similar sizes but different magnetic properties
3Manufacturing precision
If label-based methods are used for CTC separation, then the purity is improved, but the device complexity and time consumption increase due to cumbersome sample preparation
Solution Approach 1:
The patent merges the labeling and separation steps into a single integrated microfluidic device. Magnetic beads are introduced into the blood sample within the device, and the magnetic field gradient is applied concurrently to perform both labeling and separation in one continuous process, eliminating separate preparation steps and reducing overall complexity
Solution Approach 2:
The patent implements continuous flow separation where blood samples, magnetic beads, and magnetic field application occur simultaneously in a continuous manner. This eliminates batch processing steps and intermediate manipulations, reducing time consumption and operational complexity while maintaining high purity separation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device effectively separates CTCs with high recovery rates and purity, enabling comprehensive molecular analysis while preserving cell viability and biomarker expressions, overcoming limitations of existing label-based and label-free methods.
Implementation Method 1
a third stage fluidly connected to the second stage configured with a magnetic focusing force to focus magnetically labeled cells such as white blood cells
Implementation Method 2
a fluid inlet for a sheathing fluid (which may be a ferrofluid)
Implementation Method 3
configured with a magnetic focusing force to focus magnetically labeled cells
Data Source
AI summary
A variety of devices and methods are provided for separating or enriching circulating tumor cells in a biological sample such as whole blood. In some aspects, the devices are multi-stage devices including at least (i) a filtering stage, (ii) a sheath flow stage for ferrohydrodynamic separation of magnetically labelled white blood cells, and (iii) a focusing stage for marker-independent and size-independent focusing of magnetically labeled particles so as to separate or enrich unlabeled rare cells in the biological sample. The devices and methods are, in some aspects, capable of high throughput in excess of 6 milliliters per hour while achieving high separation (>95%) of the unlabeled rare cells.